Quillichew ER (Generic Name: methylphenidate hydrochloride) is the only extended-release, chewable central nervous system stimulant primarily used to treat attention deficit hyperactivity disorder (ADHD) in children ages 6-12, adolescents, and adults. It is especially useful for one-third of children who can’t swallow pills. Quillichew ER may improve focus, and decrease impulsivity and hyperactive behavior, hallmark symptoms in some patients with the condition.
It contains the same active ingredient as medications like Ritalin and Daytrana. According to the FDA, Quillichew ER is a federally controlled substance (CII) because it can be abused or lead to dependence. It has not been studied in children under the age of 6.
The American Academy of Pediatrics recommends treatment with behavioral therapy before medication for children under the age of 6. For children ages 6 to 11, the AAP says “The primary care clinician should prescribe US Food and Drug Administration–approved medications for ADHD and/or evidence-based parent- and/or teacher-administered behavior therapy as a treatment for ADHD, preferably both.” Likewise, the National Institute of Mental Health finds the most successful treatment plans use a combination of ADHD medication, like Quillichew ER, and behavior therapies.
How to Use Quillichew ER
- Before starting or refilling a Quillichew ER prescription, read the medication guide included with your pills, as it may be updated with new information.
- This guide should not replace a conversation with your doctor, who has a holistic view of your or your child’s medical history, other diagnoses, and other prescriptions. If you have questions, ask your doctor or pharmacist before you begin taking the medication.
- Decreased appetite
- Trouble sleeping
- Stomach pain
- Weight loss
- Mood swings
- Fast heartbeat
- Increased blood pressure.